TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive President Asks $989.3 Million fr NCI, But Mistake In Grant Allocations May Lead To Additional Money February 4, 1983
TCL Archive Information Branches Combined Under ICIC, Moved to Office Of NCI Deputy Director November 23, 1997
